Examining heart changes in chronic kidney disease patients with high potassium levels
The Impact of Hyperkalemia-Induced ECG and ECHO Findings on Early and Late Mortality in Patients With Chronic Kidney Disease
This study looks at how high potassium levels affect the hearts of people with chronic kidney disease who come to the emergency room to see if there are any changes in their heart size.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Saglik Bilimleri Universitesi Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06635590 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with chronic kidney disease (CKD) who present to the emergency department with isolated hyperkalemia. It involves recording pre and post-treatment ECG and echocardiographic findings to analyze the relationship between hyperkalemia levels and cardiac changes. The study does not intervene in treatment decisions and aims to monitor patient mortality at various intervals while comparing findings with existing literature. The hypothesis suggests that hyperkalemia may lead to right ventricular enlargement, which will be investigated through statistical analysis of the collected data.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with chronic kidney disease and hyperkalemia presenting to the emergency department.
Not a fit: Patients under 18, those without chronic kidney damage, or those not experiencing hyperkalemia will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of cardiac risks associated with hyperkalemia in CKD patients, potentially leading to improved management strategies.
How similar studies have performed: While the approach of examining cardiac changes in CKD patients with hyperkalemia is not widely tested, related studies have shown the importance of monitoring cardiac function in this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients over 18 years old 2. Chronic kidney disease patients with eGFR \< 60 mL/min/1.73 m² 3. Patients with hyperkalemia detected in the emergency department 4. Patients willing to participate in the study and who sign the consent form Exclusion Criteria: 1. Patients under 18 years old 2. Patients who do not wish to participate in the study 3. Patients without chronic kidney damage 4. Patients without detected hyperkalemia 5. Patients needing cardiopulmonary resuscitation due to hyperkalemia
Where this trial is running
Ankara
- Etlik City Hospital — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Gulsen AKCAY, Ass. Prof.
- Email: gulakcay@yahoo.com.tr
- Phone: +905052874949
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.